Venture Partner at Catalio Capital Management
View Live Interactive Profile →Catalio Capital Management lists Jim Allison as a Venture Partner. The firm's profile page gives the current affiliation as Director of The Parker Institute for Cancer Research, Regental Professor and Chair of the Department of Immunology. His stated honours include the Nobel Prize in Physiology or Medicine (2018), the Paul Janssen Award for Biomedical Research (2018), the Wolf Prize for Medicine (2017) and the Lasker-DeBakey Clinical Medical Research Award (2015). Catalio's page describes him as a co-founder of Jounce Therapeutics and Neon and a member of scientific advisory boards including Codiak Biosciences, Dragonfly Therapeutics and Lava Therapeutics.